Funding Support

Research in the Levings Lab is partially funded by the following grants:

 

  •  
BC Children's Hospital Research Institute: Noninvasive imaging of islet-immune cell interactions in the anterior chamber of the eye (2018)
   
  •  
HelmsleyTrust: Engineering antigen-specific regulatory T cells for use in type 1 diabetes (2018)
   
  •  
NIH: Engineering stem cells for islet cell replacement (2018)
   
  •  
Canadian Institutes of Health Research: Canadian autoimmunity standardization core (CAN-ASC) (2018)
   
  •  
Juvenile Diabetes Research Foundation International (JDRF): Harmonizing biomarkers in clinical trials of ustekinumab (2018)
   
  •  
Tx Cell SA R: Development of CAR-Tregs for Use in Transplantation (Research) (2016)
   
  •  
NIH: ITN Study: Co-Assessment Group Chair, Transplant (2018)
   
  •  
Michael Smith Foundation for Health Research: Engineered T regulatory cells to treat Crohn's disease (2018)
   
  •  
BioCanRx – NCE: Garbage to gold: Expansion of therapeutic regulatory T cells from discarded thymus (2017)
   
  •  
Canadian Institutes of Health Research: Molecular and cellular biology of T regulatory cells (2017)
   
  •   
Bristol-Myers Squibb (BMS): Defining Phenotypic and Functional Alterations of Tissue Regulatory T Cells to Assist in the Identification of Novel Targets for Next-generation Therapies in Inflammatory Bowel Disease (2016)
   
  •  
Pfizer: Tailoring Human Tregs for Cell Therapy (2016)
   
  •  
Takeda Canada: The Role of CD4+ T cell Subsets in the Mechanism of Action of Vedolizumab in Inflammatory Bowel Disease (2015)
   
  •  
Canadian Institutes of Health Research: CNTRP Core 4: Translating Strategies for Immunomodulation and Transplantation Tolerance (2013)